Matches in Wikidata for { <http://www.wikidata.org/entity/Q92486699> ?p ?o ?g. }
Showing items 1 to 43 of
43
with 100 items per page.
- Q92486699 description "article scientifique publié en 2020" @default.
- Q92486699 description "artículu científicu espublizáu en xineru de 2020" @default.
- Q92486699 description "im Januar 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q92486699 description "scientific article published on 07 January 2020" @default.
- Q92486699 description "wetenschappelijk artikel" @default.
- Q92486699 description "наукова стаття, опублікована 7 січня 2020" @default.
- Q92486699 name "Characteristics of cutaneous adverse drug reactions caused by triple-combination drug therapy used for Helicobacter pylori eradication" @default.
- Q92486699 name "Characteristics of cutaneous adverse drug reactions caused by triple-combination drug therapy used for Helicobacter pylori eradication" @default.
- Q92486699 type Item @default.
- Q92486699 label "Characteristics of cutaneous adverse drug reactions caused by triple-combination drug therapy used for Helicobacter pylori eradication" @default.
- Q92486699 label "Characteristics of cutaneous adverse drug reactions caused by triple-combination drug therapy used for Helicobacter pylori eradication" @default.
- Q92486699 prefLabel "Characteristics of cutaneous adverse drug reactions caused by triple-combination drug therapy used for Helicobacter pylori eradication" @default.
- Q92486699 prefLabel "Characteristics of cutaneous adverse drug reactions caused by triple-combination drug therapy used for Helicobacter pylori eradication" @default.
- Q92486699 P1433 Q92486699-5210A01D-AD4D-4FD6-913F-3BACBBADCFAF @default.
- Q92486699 P1476 Q92486699-3A03471D-CBA0-4D06-A531-79721548C590 @default.
- Q92486699 P2093 Q92486699-733AAD49-E561-4283-96AF-D9E7D2C87A71 @default.
- Q92486699 P2093 Q92486699-EF9D7C7D-55A0-4C53-86E9-286F64059BE8 @default.
- Q92486699 P304 Q92486699-FE3DD4BB-DBDE-4327-8525-4D006ACA00ED @default.
- Q92486699 P31 Q92486699-57E3B0A2-5A04-4554-80A3-4B3EB3BD6228 @default.
- Q92486699 P356 Q92486699-DDC71AB7-BCB3-4808-BB52-EB158AB3C13E @default.
- Q92486699 P433 Q92486699-FCCCF1A3-80A2-46F7-B7E0-151605643826 @default.
- Q92486699 P478 Q92486699-8E0FA062-3F11-41E5-95E2-165BACD3E7C4 @default.
- Q92486699 P50 Q92486699-31BF8383-F19B-4FDC-AEA3-B41467111738 @default.
- Q92486699 P50 Q92486699-42759B3D-2FB1-4B61-BD37-492AB3DB1C99 @default.
- Q92486699 P577 Q92486699-A0096022-C9E1-4369-8ACA-5B0B445EC538 @default.
- Q92486699 P698 Q92486699-BB29D232-98A7-48FB-83F0-E2379CA05116 @default.
- Q92486699 P921 Q92486699-441A8390-88A7-4290-AF34-04FC8D90564F @default.
- Q92486699 P356 1346-8138.15208 @default.
- Q92486699 P698 31912576 @default.
- Q92486699 P1433 Q18225322 @default.
- Q92486699 P1476 "Characteristics of cutaneous adverse drug reactions caused by triple-combination drug therapy used for Helicobacter pylori eradication" @default.
- Q92486699 P2093 "Akihiko Asahina" @default.
- Q92486699 P2093 "Sota Kikuchi" @default.
- Q92486699 P304 "277-282" @default.
- Q92486699 P31 Q13442814 @default.
- Q92486699 P356 "10.1111/1346-8138.15208" @default.
- Q92486699 P433 "3" @default.
- Q92486699 P478 "47" @default.
- Q92486699 P50 Q87856916 @default.
- Q92486699 P50 Q88754415 @default.
- Q92486699 P577 "2020-01-07T00:00:00Z" @default.
- Q92486699 P698 "31912576" @default.
- Q92486699 P921 Q180556 @default.